Skip to main content
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
. 2001 Mar;83(2):85–88.

Neo-adjuvant therapy improves resectability rates for colorectal liver metastases.

A Shankar 1, P Leonard 1, A J Renaut 1, J Lederman 1, W R Lees 1, A R Gillams 1, E Harrison 1, I Taylor 1
PMCID: PMC2503337  PMID: 11320935

Abstract

PURPOSE: Liver resection improves survival in selected patients with colorectal liver metastases. However, the majority of patients with colorectal liver metastases have inoperable disease at presentation. Neo-adjuvant therapy (systemic or regional chemotherapy and interstitial laser therapy) used singly or in combination may convert a selected group of patients with irresectable liver metastases into an operable state. PATIENTS AND METHODS: We report a series of patients with initially inoperable multiple colorectal liver metastases who became operable after neo-adjuvant therapy. Operability was defined as unilateral disease limited to the liver. Twelve patients (7 female, 5 male, median age 57 years, range 38-69 years) with multiple inoperable colorectal liver metastases (8 synchronous, 4 metachronous) were initially treated with systemic chemotherapy (n = 7), hepatic arterial chemotherapy (n = 2) and chemotherapy plus interstitial laser therapy (n = 3). RESULTS: In all cases, a significant response was achieved which enabled subsequent liver resection to be undertaken. There was only one postoperative complication (8%) and no peri-operative deaths. 3 patients were operated on within the last 12 months and are still alive. Of the remainder, 1 died within 1 year with recurrent disease. The remaining patients have a median survival of 2.5 years, range 1.39-4 years. CONCLUSIONS: These results are similar to those reported for patients undergoing resection for operable metastases without neo-adjuvant therapy. Aggressive multimodality treatment of colorectal liver metastases in specialised centres may improve the resectability rates and survival in a selected group of patients.

Full text

PDF
85

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen-Mersh T. G., Earlam S., Fordy C., Abrams K., Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 1994 Nov 5;344(8932):1255–1260. doi: 10.1016/s0140-6736(94)90750-1. [DOI] [PubMed] [Google Scholar]
  2. Amin Z., Bown S. G., Lees W. R. Local treatment of colorectal liver metastases: a comparison of interstitial laser photocoagulation (ILP) and percutaneous alcohol injection (PAI). Clin Radiol. 1993 Sep;48(3):166–171. doi: 10.1016/s0009-9260(05)80130-8. [DOI] [PubMed] [Google Scholar]
  3. Bismuth H., Adam R., Lévi F., Farabos C., Waechter F., Castaing D., Majno P., Engerran L. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996 Oct;224(4):509–522. doi: 10.1097/00000658-199610000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chang A. E., Schneider P. D., Sugarbaker P. H., Simpson C., Culnane M., Steinberg S. M. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 1987 Dec;206(6):685–693. doi: 10.1097/00000658-198712000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hughes K., Scheele J., Sugarbaker P. H. Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am. 1989 Apr;69(2):339–359. doi: 10.1016/s0039-6109(16)44790-0. [DOI] [PubMed] [Google Scholar]
  6. Martin J. K., Jr, O'Connell M. J., Wieand H. S., Fitzgibbons R. J., Jr, Mailliard J. A., Rubin J., Nagorney D. M., Tschetter L. K., Krook J. E. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg. 1990 Aug;125(8):1022–1027. doi: 10.1001/archsurg.1990.01410200086013. [DOI] [PubMed] [Google Scholar]
  7. Maruo H., Kosaka A. [Evaluation of cases of metastatic liver tumors resected following intra-arterial infusion chemotherapy]. Gan To Kagaku Ryoho. 1994 Sep;21(13):2143–2146. [PubMed] [Google Scholar]
  8. Scheele J. Hepatectomy for liver metastases. Br J Surg. 1993 Mar;80(3):274–276. doi: 10.1002/bjs.1800800302. [DOI] [PubMed] [Google Scholar]
  9. Tuttle T. M., Curley S. A., Roh M. S. Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol. 1997 Mar;4(2):125–130. doi: 10.1007/BF02303794. [DOI] [PubMed] [Google Scholar]
  10. Vaillant J. C., Balladur P., Nordlinger B., Karaitianos I., Hannoun L., Huguet C., Parc R. Repeat liver resection for recurrent colorectal metastases. Br J Surg. 1993 Mar;80(3):340–344. doi: 10.1002/bjs.1800800324. [DOI] [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES